These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

987 related articles for article (PubMed ID: 15720418)

  • 21. Mammary lesions diagnosed as "papillary" by aspiration biopsy: 70 cases with follow-up.
    Simsir A; Waisman J; Thorner K; Cangiarella J
    Cancer; 2003 Jun; 99(3):156-65. PubMed ID: 12811856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses.
    Jakate K; De Brot M; Goldberg F; Muradali D; O'Malley FP; Mulligan AM
    Am J Surg Pathol; 2012 Apr; 36(4):544-51. PubMed ID: 22314186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flat epithelial atypia is a common subtype of B3 breast lesions and is associated with noninvasive cancer but not with invasive cancer in final excision histology.
    Noske A; Pahl S; Fallenberg E; Richter-Ehrenstein C; Buckendahl AC; Weichert W; Schneider A; Dietel M; Denkert C
    Hum Pathol; 2010 Apr; 41(4):522-7. PubMed ID: 20004938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy.
    Sydnor MK; Wilson JD; Hijaz TA; Massey HD; Shaw de Paredes ES
    Radiology; 2007 Jan; 242(1):58-62. PubMed ID: 17090707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal invasive biopsy results of "uncertain malignant potential" in digital mammography screening: high prevalence but also high predictive value for malignancy.
    Weigel S; Decker T; Korsching E; Biesheuvel C; Wöstmann A; Böcker W; Hungermann D; Roterberg K; Tio J; Heindel W
    Rofo; 2011 Aug; 183(8):743-8. PubMed ID: 21506072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
    Renshaw AA; Derhagopian RP; Martinez P; Gould EW
    Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy.
    Jaffer S; Nagi C; Bleiweiss IJ
    Cancer; 2009 Jul; 115(13):2837-43. PubMed ID: 19402174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
    Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
    Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies.
    Renshaw AA; Cartagena N; Schenkman RH; Derhagopian RP; Gould EW
    Am J Clin Pathol; 2001 Jul; 116(1):92-6. PubMed ID: 11447758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large volume "mammotome" biopsy may reduce the need for diagnostic surgery in papillary lesions of the breast.
    Carder PJ; Khan T; Burrows P; Sharma N
    J Clin Pathol; 2008 Aug; 61(8):928-33. PubMed ID: 18495791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasonography-guided core needle biopsy in differential diagnosis of papillary breast tumors.
    Bode MK; Rissanen T; Apaja-Sarkkinen M
    Acta Radiol; 2009 Sep; 50(7):722-9. PubMed ID: 19488890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Papillary lesions initially diagnosed at ultrasound-guided vacuum-assisted breast biopsy: rate of malignancy based on subsequent surgical excision.
    Chang JM; Han W; Moon WK; Cho N; Noh DY; Park IA; Jung EJ
    Ann Surg Oncol; 2011 Sep; 18(9):2506-14. PubMed ID: 21369740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
    El-Sayed ME; Rakha EA; Reed J; Lee AH; Evans AJ; Ellis IO
    Histopathology; 2008 Dec; 53(6):650-7. PubMed ID: 19076681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papillary lesions of the breast: selected diagnostic and management issues.
    Collins LC; Schnitt SJ
    Histopathology; 2008 Jan; 52(1):20-9. PubMed ID: 18171414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Management of non-malignant results in core needle biopsy of breast lesions].
    Fan ZQ; Ouyang T; Li JF; Wang TF; Xie YT; Fan T; Zhang Z; Lin BY
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(34):2387-90. PubMed ID: 19087711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy.
    Dillon MF; McDermott EW; Hill AD; O'Doherty A; O'Higgins N; Quinn CM
    Ann Surg Oncol; 2007 Feb; 14(2):704-11. PubMed ID: 17151788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast fine needle aspiration cytology. Utility as a screening tool for clinically palpable lesions.
    Costa MJ; Tadros T; Hilton G; Birdsong G
    Acta Cytol; 1993; 37(4):461-71. PubMed ID: 8328240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
    Rakha EA; Lee AH; Jenkins JA; Murphy AE; Hamilton LJ; Ellis IO
    Int J Cancer; 2011 Sep; 129(6):1417-24. PubMed ID: 21128240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.